We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTA
13351
CALL
Metalla Royalty & Streaming
MTA
$912M
$14.8K ﹤0.01%
5,900
+5,700
+2,850% +$18.1K
THRY icon
13352
PUT
Thryv Holdings
THRY
$96M
$14.8K ﹤0.01%
1,000
-400
-29% -$6.3K
ACHV icon
13353
CALL
Achieve Life Sciences
ACHV
$779M
$14.8K ﹤0.01%
4,200
-18,400
-81% -$83.4K
HTO
13354
CALL
H2O America
HTO
$2.67B
$14.8K ﹤0.01%
300
-100
-25% -$5.51K
FMBH icon
13355
CALL
First Mid Bancshares
FMBH
$1.38B
$14.7K ﹤0.01%
+400
New +$15.9K
JBIO
13356
Jade Biosciences
JBIO
$1.57B
$14.7K ﹤0.01%
+159
New +$13.7K
LTRN icon
13357
CALL
Lantern Pharma
LTRN
$33.8M
$14.7K ﹤0.01%
4,600
-35,200
-88% -$121K
PKE icon
13358
CALL
Park Aerospace
PKE
$831M
$14.7K ﹤0.01%
1,000
+700
+233% +$10.1K
OHI icon
13359
Omega Healthcare
OHI
$14.1B
$14.6K ﹤0.01%
387
-1,269
-77% -$50.7K
CON
13360
PUT
Concentra Group Holdings
CON
$4.52B
$14.6K ﹤0.01%
740
+640
+640% +$13.2K
LXP icon
13361
PUT
LXP Industrial Trust
LXP
$3.57B
$14.6K ﹤0.01%
360
+220
+157% +$10.2K
IHS icon
13362
CALL
IHS Holding
IHS
$2.82B
$14.6K ﹤0.01%
5,000
-600
-11% -$1.82K
CTSO icon
13363
CALL
Cytosorbents Corp
CTSO
$25.1M
$14.6K ﹤0.01%
16,000
+600
+4% +$589
TGB
13364
PUT
Trekor Metals
TGB
$3.06B
$14.6K ﹤0.01%
7,500
-95,100
-93% -$210K
SRTS icon
13365
PUT
Sensus Healthcare
SRTS
$47.1M
$14.5K ﹤0.01%
2,100
+1,300
+163% +$9.53K
TSL icon
13366
PUT
GraniteShares 1.25x Long TSLA Daily ETF
TSL
$11.9M
$14.5K ﹤0.01%
800
-3,800
-83% -$52.9K
PMCB icon
13367
CALL
PharmaCyte Biotech
PMCB
$5.92M
$14.4K ﹤0.01%
+9,300
New +$16K
INBK icon
13368
PUT
First Internet Bancorp
INBK
$254M
$14.4K ﹤0.01%
400
-3,500
-90% -$133K
MITQ icon
13369
Moving iMage Technologies
MITQ
$5.47M
$14.3K ﹤0.01%
22,026
-23,238
-51% -$14.4K
CYD icon
13370
PUT
China Yuchai International
CYD
$1.7B
$14.3K ﹤0.01%
+1,500
New +$15.8K
AFYA icon
13371
PUT
Afya
AFYA
$1.27B
$14.3K ﹤0.01%
900
+700
+350% +$11.5K
PDBC icon
13372
PUT
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
$14.3K ﹤0.01%
+1,100
New +$14.8K
NWG icon
13373
CALL
NatWest
NWG
$76B
$14.2K ﹤0.01%
1,400
+700
+100% +$6.93K
VRCA icon
13374
Verrica Pharmaceuticals
VRCA
$85.4M
$14.2K ﹤0.01%
+2,029
New +$22.3K
AIFU
13375
CALL
AIFU Inc
AIFU
$215M
$14.2K ﹤0.01%
32
-19
-37% -$10.1K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.